Format

Send to

Choose Destination
N Engl J Med. 2017 Mar 2;376(9):890-1. doi: 10.1056/NEJMc1615712.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Author information

1
Harbor–UCLA Medical Center, Torrance, CA. ipp@labiomed.org
2
Los Angeles Biomedical Research Institute, Torrance, CA
3
Harbor–UCLA Medical Center, Torrance, CA
PMID:
28252263
DOI:
10.1056/NEJMc1615712
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center